Home » Topics » Regulatory

Regulatory
RSS

Hoechst Marion Roussel files for new indication of Refludan in U.S. and E.U.

July 15, 1999

Nastech completes phase III testing of intranasal scopolamine

July 13, 1999

Allergan ciclosporin NDA up for review this month by advisory committee

July 12, 1999

FDA advisory committee to consider OTC status for Flexeril

July 9, 1999

Pediatric formulation of Viramune now available in the E.U.

July 9, 1999

Novo Nordisk seeks approval for liquid GH in the U.S.

July 5, 1999

TAP Holdings seeks approval of erectile dysfunction treatment

July 2, 1999

FDA approves new formulation of Abbott's Norvir

July 1, 1999

Alza's Doxil approved in U.S. for treatment of refractory ovarian cancer

July 1, 1999

Genentech submits NDA to FDA for Nutropin Depot

June 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...